Bhagwan is powering rigs, renewables and more
Oil rigs are firing up, decommissioning’s a $60bn goldmine, and Bhagwan’s eyeing renewables and defence for the long haul.
Oil rigs are firing up, decommissioning’s a $60bn goldmine, and Bhagwan’s eyeing renewables and defence for the long haul.
DLE could play a pivotal role in reducing the impact of a looming lithium supply deficit.
Gold juniors are catching the wave of high prices, drilling down in the hunt for new discoveries as investors catch a case of gold fever.
ASX pares gains after Trump’s tariffs threat sends nerves through the market. Meanwhile, Bitcoin slips as it awaits a bit more clarity from the new POTUS.
ASX miners are entering the trenches for their quarterly showdowns with analysts, with BHP and LTR’s December reports impressing.
ASX lifts with banks, BHP; Trump boosts markets, Liontown triples output and Northern Star is on track.
ASX expected to drop on Wednesday; Nvidia surges 7%. Flutter Entertainment falls 7% due to Illinois sports betting tax
DeSoto Resources got off to a flyer this morning, on the back a new rare earths acquisition in the NT.
Local markets were down again this morning, with the benchmark dropping sharply at open to be around -0.75% at lunchtime, as the market digested some unpleasant news from the ABS about the Consumer Price Index.
Aussie stocks fell 1pc on rising inflation. IAG hit by class action lawsuit. IMF ups China’s growth forecast to 5pc.
Good morning, and Happy Thursday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
Local markets have completed a worrisome trifecta this morning, losing ground for the third session in a row after a woeful effort on Wall Street overnight set the stage for more losses.
After more than US$3.5 TRILLION was wiped off the S&P 500 overnight, niobium rises. And wait, is nickel back in vogue?
Local investors found relief as the ASX resisted the global markets decline, while the RBA maintained its current policies.
Hydrogen driller Hyterra gets $21.9m investment from FMG and MC Mining flies on US$90m Chinese investment in South African coal.
Miners shot higher but Web Travel Group plunged after a trading update revealed declining EBITDA margins despite increased Total Transaction Value and bookings.
Radiopharm Theranostics appears to be emerging from unloved status to that of a genuine contender in the red-hot radiopharmaceutical sector.
Drill results have Tony Leibowitz and John Young’s lithium play Astute Metals on the up; White House cash lifts Ioneer and Element 25.
The ASX edged up on Monday, with Trump in focus and banks propping things up locally. Meanwhile, Bitcoin and crypto dipped and the Star tanked.
With the US regulator ticking off its manufacturing facilities, EBR is girding for approval of its novel heart lead in April and commercialisation by the end of the year.
Fraser Palamara investigates Island Pharmaceuticals and an antiviral drug development making strides against dengue fever.
Asia is expected dominate oil and gas demand growth, a forecast that provides plenty of opportunities for ASX-listed companies in the space.
After a busy 2024, Summit Minerals has kicked off 2025 by announcing the potential acquisition of a new REE and niobium project in Brazil.
With gold prices at record highs ASX juniors don’t need a world class mine to print cash, John Forwood says.
Macquarie’s $7 billion green energy push is helping to drive the future of renewables and clean tech.
Gold miners are ramping up their cash generation with bullion prices lifting to a five-month high and December reports flowing.
Condor Energy and Green Critical Minerals were leading the ressie pack on Friday, fuelled by Thursday’s news.
ASX bank stocks fell on Friday but mining stocks rose as talk of a potential mega merger between Rio Tinto and Glencore turned heads.
Two of the world’s biggest diggers held talks about creating the world’s biggest miner, according to media reports.
Maiden resource estimates represent a key moment in a project’s development. Here are some companies looking to reveal one this year.
The ASX dips but recovers at lunch on Friday, while gold and Bitcoin surge and CC Capital hikes Insignia bid.
Boss Energy leads the ASX’s most shorted stock list, with uranium and lithium miners continuing to draw the attention of bears.
Sarah Hughan dives into EBR Systems and its development of a one-of-a-kind leadless pacemaker to fill a void in health of the heart.
Pro Medicus has signed a $33M deal with the University of Kentucky (UK Healthcare), while Memphasys pushes RoXsta to the forefront of antioxidant diagnostics.
Tony Locantro offers a stacked pack of Australian biotech nuggets for hungry investors to weigh up for their portfolios in 2025.
Final figures for Australia’s ETF industry in 2024 have dropped with crypto and tech-focussed ETFs topping the performance table.
Analysts say China’s EV market is ripe for investment as US looks to boost battery metals by securing a friendlier supply chain.
Condor Energy led the gainers in the resources and energy space with a big lift in contingent resources at the Piedra Redonda gas field in Peru.
The ASX ripped higher on Thursday on banks and jobs boost. Meanwhile Zip and Tabcorp rocketed and oil spiked on supply fears.
Sarah Hughan investigates iTech Minerals and the focus on graphitic growth at its advanced Eyre Peninsula project in South Australia.
Fraser Palamara pontificates on a big contract for MLG Oz as the mining services company continues to build its revenue base.
The ASX rises on strong US CPI and bank profits, while Rio Tinto misses ore targets and Tabcorp surges with a new exec.
In this episode, host Sarah Hughan recaps the past 12 months for DXB and discusses what they have coming up in 2025.
We’re on the edge of an AI boom, and ASX semiconductor stocks – including those focused on graphene, neuromorphic chips, and quantum tech – are ready to cash in.
In this episode, host Fraser Palamara recaps the past 12 months for Race Oncology and discusses what it has coming up in 2025.
Strickland’s gold in Serbia’s got upside, while Aura’s Tiris Uranium project is set to grow – both speculative buys according to WA brokers.
Juniors who have leapt on record gold prices to start small gold mines have prospered in recent months. Who’s next on the list?
Blue chip and mid-tier miners are about to deliver December reports. Here’s why brokers see value emerging in the resources sector.
Rare earths continue to grab ressie limelight with Ark Mines’ 21.7Mt REE resource reveal.
ASX down as weekly loss surpasses 2pc. Mining and energy stocks main laggards today.
Good morning, and Happy Friday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
Reach is today’s high-grade niobium winner today, leading the resources sector gains.
Good morning, and Happy Thursday! Here’s everything you need (and some stuff you don’t need) to know before the ASX opens today.
The annual Noosa Mining Investor Conference in Queensland’s Sunshine Coast has developed over the years to become one of the resources industry’s ‘must attend’ events on the East Coast.
ING commodity strategist Ewa Manthey and Saxo’s Ole S. Hanson ran the scenarios for gold ahead of the US Presidential Election.
WA stockbroker and mining experts Argonaut has lifted the lid on this year’s list of best undeveloped ASX projects, and another six that are worthy of special mentions.
The ASX dipped on Wednesday as CSL and Brambles dragged. Meanwhile Pilbara, and Arafura soared on funding, and all eyes are on the US CPI.
Arafura Rare Earths has been earmarked as the first mine investment for a $15bn federal fund; WGR edging closer to gold producer status.
ASX ticks up ahead of US CPI report, Bitcoin hits $97K, while iron ore and real estate lead the charge.
Stockhead recaps the successes of 2024 for Airtasker the milestones planned for the new year.
Guy Le Page casts his gaze over Sarama Resources and a recent acquisition of some surprisingly unexplored greenstone.
Neuren’s partner Acadia Pharmaceuticals submits marketing authorisation application in Europe for trofinetide for treatment of Rett syndrome.
New data shows the 40 key ASX biotechs gained an average 50% in 2024 – but not everyone was a winner.
US President-elect Donald Trump’s interest in Greenland has brought its resource bounty into the limelight.
Studies show outperformance of founder-led companies for investors, including one from Credit Suisse and numerous listed on the ASX.
Despite optimism that inflation would swiftly retreat, the latest numbers tell a different story. So what does this mean for investors?
Tim Goyder’s Minerals 260 has emerged as the latest junior to ink a big gold deal, offering $166 million for Zijin’s 2.3Moz Bullabulling.
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new copper project acquisition in Chile from Pan Asia Metals.
New copper supply is needed ASAP and Chile’s nimbler junior copper plays could be better placed than majors to bridge the gap.
The Serbian government reinstated Rio’s licence to develop the 58,000tpa Jadar lithium mine, but protesters have environmental concerns.
APRA has mandated ANZ to raise risk capital by $250 million for ongoing management issues, while Tabcorp gets a $4.6 million fine.
Benchmark flatlines despite strong Resources surge, while Star sinks like a stone.
Stockhead has stuffed a collection of ASX lithium companies with plenty of exploration upside into a stocking for you.
Copper is looking red hot out to 2050, with demand tipped to hit 50Mt and prices set to soar to US$17,000/t.
The ASX rebounded, with mining and energy stocks up. Meanwhile Star also bounced, thanks to a Macau backer, and TikTok may sell US arm to Elon Musk.
A potash company backed by Owen Hegarty’s EMR Capital received a boost as FIRB approved an investment from China Inc.
The ASX has bounced back a bit with energy and mining stocks rallying, while a mystery Macau investor scoops up Star Entertainment.
Battery metals king Tim Goyder, largest shareholder of Minerals 260, raises the gold banner with a blockbuster project acquisition.
In this episode, host Sarah Hughan recaps the past 12 months for Lumos Diagnostics and discusses what it has coming up in 2025.
Big Tech is paying dividends on Wall Street and ASX tech stocks Dicker Data and Reckon, among others, are jumping on the bandwagon.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/5